Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
KRLS-004 by Kirilys Therapeutics for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
KRLS-004 is under clinical development by Kirilys Therapeutics and currently in Phase I for Head And Neck Squamous Cell Carcinoma...
KRLS-004 by Kirilys Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
KRLS-004 is under clinical development by Kirilys Therapeutics and currently in Phase I for Non-Small Cell Lung Cancer. According to...
KRLS-004 by Kirilys Therapeutics for Renal Cell Carcinoma: Likelihood of Approval
KRLS-004 is under clinical development by Kirilys Therapeutics and currently in Phase I for Renal Cell Carcinoma. According to GlobalData,...
KRLS-004 by Kirilys Therapeutics for Solid Tumor: Likelihood of Approval
KRLS-004 is under clinical development by Kirilys Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
KRLS-004 by Kirilys Therapeutics for Liver Cancer: Likelihood of Approval
KRLS-004 is under clinical development by Kirilys Therapeutics and currently in Phase I for Liver Cancer. According to GlobalData, Phase...
KRLS-004 by Kirilys Therapeutics for Colorectal Cancer: Likelihood of Approval
KRLS-004 is under clinical development by Kirilys Therapeutics and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...
KRLS-004 by Kirilys Therapeutics for Ovarian Cancer: Likelihood of Approval
KRLS-004 is under clinical development by Kirilys Therapeutics and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase...
KRLS-004 by Kirilys Therapeutics for Breast Cancer: Likelihood of Approval
KRLS-004 is under clinical development by Kirilys Therapeutics and currently in Phase I for Breast Cancer. According to GlobalData, Phase...